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TIMP-1 and MMP-9/TIMP-3 were still higher in the lesions from unstable (0.24 + 0.07
and 1.47 + 0.39) than in those from stable (0.09 + 0.05 and 0.53 + 0.19) patients. Immu-
nohistochemistry localized both MMP-9 and TIMPs in macrophages some of which were
expressed in the fibrous cap of the ruptured plaque.
Conclusions: Upregulation of MMP-9 in the plaques from unstable coronary patients
was disproportional to that of TIMPs, suggesting that active degradation of extracellular
matrix persists in advanced coronary lesions particularly in those from clinically unstable
patients.
1042-80 Ischemia Modified Albumin Improves the Sensitivity and 
Negative Predictive Value of Standard Cardiac 
Biomarkers for the Diagnosis of Myocardial Ischemia
Saif Anwaruddin, James L. Januzzi, Jr., Kent B. Lewandrowski, Elizabeth Lewandrowski, 
Massachusetts General Hospital, Boston, MA
Introduction: We examined the utility of ischemia modified albumin (IMA), both alone
and with standard biomarkers of cardiac myonecrosis, for the assessment of patients
with suspected myocardial ischemia in the emergency department.
Methods: 200 consecutive patients presenting to the emergency department with symp-
toms suggestive of myocardial ischemia were evaluated.Measurement of troponin I (TnI),
creatine kinase-MB (CK-MB), and myoglobin (Myo) were performed on each patient
using a quantitative bedside point of care assay (Biosite, LaJolla, CA) as well as mea-
surement of the IMA with the Albumin Cobalt Binding (ACB) assay (Ischemia Technolo-
gies, Denver, CO). Every case (including history, physical, electrocardiogram, stress test
and angiography, if applicable) was reviewed, in a blinded fashion, by a cardiologist. A
clinical diagnosis of ischemia was assigned based on these data, and then correlated to
the results of the biomarker testing.
Results: 13% of the patients were judged to have myocardial ischemia by clinical data.
Compared to those patients without ischemia, patients with a clinical diagnosis of
ischemia were older (70.5 ± 16.9 vs 65.4 ± 16.9 years, p<0.001), and were more likely to
have had a prior diagnosis of coronary artery disease (67% vs 26%, p<0.001) or prior
revascularization (28% vs 10%, p=0.002). Furthermore, those patients with ischemia
were more likely to have congestive heart failure (20% vs 6%, p=0.002). Utilizing a cut-
point of 90 unit/ml, we found the ACB assay to have 83% sensitivity and 30% specificity
for the diagnosis of ischemia, with a negative predictive value of 92%. Among the same
group of patients, the triple screen of CK-MB/TnI/Myo had a sensitivity of only 57%. The
combination of IMA/CK-MB/TnI/Myo increased the sensitivity for the detection of
ischemia to 97%, with a negative predictive value of 92%.
Conclusion: When used in patients with suspected myocardial ischemia, the ACB assay
for IMA has high sensitivity and negative predictive values. Furthermore, IMA measure-
ment improves the sensitivity of CK-MB/TnI/Myo for the detection of acute coronary
ischemia.
1042-81 Increased Expression of Myeloid Related Protein in 
Infiltrated Neutrophils in Coronary Atherosclerotic 
Plaques of Patients With Unstable Angina
Shoichi Miyamoto, Masaki Ikemoto, Makiko Ueda, Takahiko Naruko, Akira Itoh, Koji 
Hasegawa, Masatoshi Fujita, Kyoto University, Kyoto, Japan, Osaka City University, 
Osaka, Japan
Background: Myeloid related protein (MRP) is expressed in infiltrated neutrophils and
macrophages during inflammatory reactions. The purpose of this study was to investi-
gate; (1) whether serum MRP levels are increased in patients with unstable angina (UA),
(2) whether MRP levels are upregulated in coronary atherosclerotic plaques of patients
with UA. Methods: Serum MRP levels were measured using a sandwich enzyme-linked
immunosorbent assay system which was newly developed in our laboratory in 53
patients [64±13 (SD) years] with UA (Braunwald’s classification II and III) and 39 patients
(64±11 years) with stable angina (SA), and serum C reactive protein (CRP) levels were
also measured. In addition, we immunohistochemically studied the presence of MRP in
directional coronary atherectomy specimens, obtained from the different 25 patients
(59±10 years) with UA and 26 patients (56±12 years) with SA. The presence of MRP
immunoreactivity was quantified using a computer-aided planimetry. For the identification
of the cell types which stain positive for MRP, immunodouble staining was also per-
formed. Results: There were no significant differences between the two groups regard-
ing age, sex, risk factors, and angiographic findings. Serum MRP levels were significantly
higher in patients with UA than in SA (3.25±3.08µg/ml vs. 0.77±0.31µg/ml, p<0.0001).
Serum CRP levels were also significantly higher in patients with UA than in SA
(3.11±6.14mg/dl vs. 0.19±0.20mg/dl, p<0.005). The percentage of MRP positive area
was significantly higher in patients with UA than in those with SA (18.3±14.2% vs.
1.3±2.4%, p<0.0001). In patients with UA, the immunodouble staining clearly revealed
that MRP was expressed in infiltrated neutrophils and occasional macrophages. Conclu-
sion: The measurement of serum MRP levels and the immunohistochemical approach
are useful for the differentiation between UA and SA. MRP may be involved in vulnerabil-
ity of coronary atherosclerotic plaques in patients with UA.
1042-82 White Blood Cell Count Predicts Higher Risk of 
Intermediate-Term Outcomes in Patients Stabilized 
After Acute Coronary Syndromes: Observations From 
the SYMPHONY and 2nd SYMPHONY Trials
Gustavo B.F. Oliveira, L. Kristin Newby, Lauren Lindblad, Leopoldo S. Piegas, Freek W. 
Verheught, Robert A. Harrington, Judith S. Hochman, Harvey D. White, Frans Van de 
Werf, Christopher B. Granger, Duke Clinical Research Institute, Duke University Medical 
Center, Durham, NC, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
Background: As a marker of inflammation, the white blood cell count (WBCc) is widely
available, has WHO-defined laboratory assay standards and excellent interassay preci-
sion (coefficient of variation <3%), and has been shown to be associated with acute cor-
onary syndromes (ACS) at presentation and clinical outcomes. Little is known about later
WBCc in initially stabilized ACS patients. Methods: Our hypothesis was that WBCc
would be an independent predictor of death (at 90 days and 1 year), and recurrent
ischemic events at 90 days, in patients with unstable angina or myocardial infarction who
were clinically stable for at least 12 hours. WBCc were collected at 3 days (median) in
9015 patients from the SYMPHONY and 2nd SYMPHONY trials. The continuous and
dichotomized (median 7600/mm3) relationships of WBCc with baseline characteristics
and outcomes were examined. Results: Patients with higher WBCc were younger and
heavier, more often male, diabetic and current smokers, had higher estimated creatinine
clearance, more congestive heart failure, but less often had prior ACS. Statins, beta-
blockers, aspirin and percutaneous coronary intervention were used more frequently in
these patients. In adjusted models, the HRs per 10-increase in continuous WBCc were
2.4 (1.35-4.28) and 1.89 (1.14-3.12) for 90-day and 1-year death, respectively (P-
value<0.0001). Conclusion: WBCc is a strong predictor of death and recurrent ischemic
events in the full spectrum of ACS patients, even after an initial stabilization.
1042-83 Detection of Increased Blood Temperature in the 
Coronary Sinus of Patients With Coronary Artery 
Disease: The Impact of Temperature Measurements on 
Prognosis
Sophia Vaina, Konstantinos Toutouzas, John Mitropoulos, Eleftherios Tsiamis, Christos 
Pitsavos, Harissios Boudoulas, Christodoulos Stefanadis, Hippokration Hospital, Athens, 
Greece
Background: Widespread inflammation is observed in patients (pts) with coronary artery
disease (CAD), possibly resulting in increased temperature in the coronary sinus (CS)
blood. Our study aimed to test whether increased CS blood temperature in pts with CAD
is related to prognosis. Methods: We enrolled 47 pts undergoing coronary angiography,
for evaluation of recent onset of chest pain. Temperature measurements were performed
by a CS thermography catheter (Medispes, ZWG, Switzerland), previously validated. As
temperature difference (∆T) was designated the difference between CS and right atrium
(RA) blood temperature. Study's end-points were: recurrent angina, myocardial infarction
(MI) and cardiac death. Mean follow-up period was 8.7±3 months. Results: The mean
blood temperature was lower in the RA compared to the CS (38.07±0.3
vs.38.28±0.4°C,p<0.001). During follow-up 2 pts suffered from MI, 1 died after coronary
artery bypass surgery and 6 had a repeat revascularization procedure. The incidence of
adverse cardiac events in pts with ∆T>0.25°C was 34.78% and in pts with ∆T<0.25°C
was 4.16%(p<0.01). The relative risk of adverse cardiac events in pts with ∆T>0.25°C
was significantly increased (RR = 8.36,p<0.05). A Cox survival plot stratified for the cut-
off point showed a clear relationship between ∆T and event-free survival (Figure). Con-
clusions: This study suggests, that increased blood temperature in the CS is a predictor
for adverse cardiac events in a mid-term follow-up period in pts with CAD.
Outcomes by Baseline WBC Count
WBC> 
7600/mm3
WBC< 
7600/mm3
Hazard Ratio (95% CI) P-value
90-day Death, % 1.9 1.1 3.0 (1.70-5.34) 0.0002
90-day Death or MI, % 7.1 5.9 1.5 (1.13-2.10) 0.007
90-day Death /MI /SRI, % 9.3 8.1 1.4 (1.05-1.82) 0.02
1-year Death, % 2.8 1.1 2.0 (1.23-3.31) 0.005
